Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02007031
Other study ID # 24300771KYTEM
Secondary ID
Status Completed
Phase N/A
First received December 5, 2013
Last updated December 10, 2013
Start date January 2010
Est. completion date November 2011

Study information

Verified date December 2013
Source University of Oulu
Contact n/a
Is FDA regulated No
Health authority Finland: Ethics Committee
Study type Observational

Clinical Trial Summary

Wintertime is associated with increased morbidity and mortality and a majority is related to cardiovascular causes, such as myocardial infarctions, heart failures, and strokes. It is also known, that both acute and long-term cold exposure increase blood pressure and cardiac workload, and this may contribute to the observed excess morbidity and mortality during the cold season.

Although the effects of cold on blood pressure are known among healthy people, these responses among risk groups, such as hypertensive people, are not established. In addition, changes in cardiac electrical activity or autonomic regulation are largely unknown. The cardiovascular responses in the cold could be different among hypertensive people because of disturbances in the circulatory regulation or function, such as aortic stiffening and increased vasomotor tone of peripheral arteries due to endothelial dysfunction associated with the disease. To assess this, a controlled experiment employing a cold exposure similar to everyday winter circumstances in a subarctic climate was performed.


Description:

Introduction.

Wintertime is associated with increased morbidity and mortality and a majority is related to cardiovascular causes, such as myocardial infarctions, heart failures, and strokes. It is also known, that both acute and long-term cold exposure increase blood pressure and cardiac workload, and this may contribute to the observed excess morbidity and mortality during cold season.

Although the effects of cold on blood pressure are established among healthy people, the effects among risk groups, such as hypertensive people, are not known. In addition to blood pressure, information on cardiac electrical activity or autonomic regulation are needed. Cardiovascular responses in the cold could be different among hypertensive people because of disturbances in autonomic nervous system and the circulatory regulation or function, such as aortic stiffening and increased vasomotor tone of peripheral arteries due to endothelial dysfunction associated with the disease. To assess this, a controlled experiment employing a cold exposure similar to everyday winter circumstances in a subarctic climate was performed in a climatic chamber.

Aims of the research.

The objective of the research was to assess how short-term cold exposure affects cardiovascular function of middle-aged untreated hypertensive and normotensive men. The hypotheses of the study were: a) cold exposure induces adverse changes in cardiovascular function, such as higher blood pressure and cardiac workload and b) hypertensive men demonstrate an aggravated response to cold exposure and the recovery of the cardiovascular system to baseline is delayed compared to normotensive subjects.

Material and Methods.

Study participants.

The study participants were chosen through a population-based recruitment and where a random sample of 1000 men (55-65 years old) living in Oulu, Finland was drawn from the Finnish Population Register. The subjects were screened by telephone interviews for eligibility for the study. Eligible attendees measured their blood pressure at home for a week according to the recommendations of the European Society of Hypertension. Based on these measurements they were classified either to hypertensive (systolic blood pressure ≥135 and/or diastolic blood pressure ≥85 mmHg) or normotensive (blood pressure <135/85mmHg).(16) The exclusion criteria was the presence of coronary heart or respiratory diseases, use of antihypertensive drugs for any indication, an average home BP ≥175/105 mm Hg, and failed home BP measurements. We aimed at recruiting a 2:1 ratio of hypertensive and normotensive subjects. The final study group consisted of 56 hypertensive and 35 normotensive middle-aged men.

Measurement protocol.

Before the measurements the participants filled a questionnaire with health and cold habituation related questions. The laboratory experiments began with a short familiarization to the measurement protocol and climatic chambers. Height, body composition, and physical fitness of the subjects were measured.

The participants were exposed for 15 min to temperature of -10°C and wind of 3m/s while protected from the cold with proper winter clothing, i.e. conditions similar to common habitual winter time cold exposure in subarctic countries. Participants were followed 15 min before (control measurements) and 20 min after (recovery) the exposure in a climatic chamber where the temperature was adjusted to +18°C and wind was set to <0.2m/s). The participants were standing with their arms supported during the measurements.Cardiovascular function was assessed by measuring brachial, central aortic, and continuous "beat to beat" blood pressure, as well as ECG measurements. The intensity of cold exposure was evaluated with skin temperature measurements (middle finger, back of the hand, shoulder blade, and cheek) and by assessing thermal perception for the whole body and face using subjective judgement scales.

The collected data was analyzed to assess the cold related changes in blood pressure (brachial and central aortic) and heart rate. ECG morphology and vector cardiographic parameters were computed from derived 12-lead ECG recordings at the Institute of Clinical Medicine at University of Oulu. Arrhythmias were detected automatically and confirmed with visual inspection by trained health care professional. To assess the regulation of circulation, continuous blood pressure signal and simultaneously recorded three lead ECG are applied to compute baroreflex sensitivity and heart rate variability at the Verve research center. In the data analyses responses to cold exposure will be evaluated and compared between hypertensive and normotensive subjects. In addition to the above mentioned topics combined risk factors for adverse changes in cardiovascular function during cold exposure will be evaluated, such as high arterial stiffness, altered ECG, and low heart rate variability. Based on this, a profile of a high risk patient will be defined and shared with physicians treating hypertensive patients to reduce adverse cold-related cardiac events.

Site of research and availability of equipment and services required for the research.

The laboratory measurements were implemented in the climatic chambers of Kastelli Research Center, Oulu, Finland. The data analyses and reporting are performed in facilities of Center for Environmental and Respiratory Health Research (University of Oulu). In addition, data analyses are performed in the Oulu University Hospital and at Verve department of Exercise and Cardiac rehabilitation.

Co-operation.

The Center for Environmental and Respiratory Health Research - Adjunct professor Tiina M Ikäheimo, Professor Jouni JK Jaakkola, Professor J Hassi, PhD A Rantala, MHSc H Hyrkäs; Department of Exercise and Medical Physiology, Verve, Oulu - Adjunct professor M Tulppo, Adjunct professor A Kiviniemi, Adjunct professor Arto Hautala; Institute of Occupational Health, Oulu - Professor H Rintamäki; Institute of Clinical Medicine, University of Oulu - Professor H Huikuri, PhD T Kenttä; Institute of Biomedicine, Department of Physiology and Biocenter of Oulu, University of Oulu - Professor KH Herzig; Institute of Health Sciences, University of Oulu - Professor S Keinänen-Kiukaanniemi, Professor R Antikainen, Professor M Mäntysaari; Department of Biology - Professor E Hohtola; Oulu University of Applied Sciences - Principal lecturer of Medical Engineering J Jauhiainen.

Ethical issues.

The study was approved by the ethics committee of Northern Ostrobothnia Hospital District (statement number 240/2010) and all participants were informed of the study and were requested for informed consent. They had also the possibility to terminate the study at any point. The data collected during the study is maintained unavailable from other than project personnel and protected with passwords. Data-analyses are performed without any personal identification (name, address etc.). The research applied a short cold exposure with well protected subjects and did not, therefore, cause any pain or harm to the participants.

Implications.

WHO has defined high blood pressure as the leading global risk for mortality in the world. Approximately half of the middle-aged men and one third of women have hypertension in Finland. On the other hand, with proper blood pressure control the risk of adverse cardiovascular events among hypertensive patients can be considerably reduced.

Wintertime and cold weather remarkably increase the risk of cardiovascular morbidity and mortality. There is an excess of ca. 2000-3000 deaths occurring in Finland during the winter and even half of them are for cardiovascular reasons. Both acute and and repeated exposures to cold increase blood pressure and may contribute to the higher wintertime cardiovascular morbidity and mortality. It has been suggested, that cold-related cardiovascular deaths could be prevented by proper protection from cold temperature.

The study will produce novel information of cardiovascular responses to short-term cold exposure among untreated hypertensive men. This knowledge will help health care personnel to advice hypertensive patients to protect themselves during habitual cold exposure, which could reduce the adverse cardiac events related to the cold weather. This knowledge is useful for medical doctors when considering medication for their patients. In addition, hypertensive people may need advice for their proper protection to reduce cold-related changes in cardiovascular function, such as blood pressure increases, and the related adverse cardiovascular events in cold climates.


Recruitment information / eligibility

Status Completed
Enrollment 91
Est. completion date November 2011
Est. primary completion date November 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 55 Years to 65 Years
Eligibility Inclusion Criteria:

- Measured BP (home measurements of one week) above 135/85 mmHg were selected to the group of hypertensive subjects.

- Those with BP below 135/85 mmHg were selected as controls.

Exclusion Criteria:

- Presence of coronary heart disease, respiratory diseases, and the use of antihypertensive drug treatment.

- an average home BP =175/105 mmHg, initiating antihypertensive drug treatment, failed home BP measurements, and having a respiratory infection within a week prior to the controlled measurements

Study Design

Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
Finland Finnish Institute of Occupational Health Oulu
Finland University of Oulu Oulu

Sponsors (4)

Lead Sponsor Collaborator
University of Oulu Finnish Institute of Occupational Health, National Institute for Health and Welfare, Finland, Verve Research, Oulu, Finland

Country where clinical trial is conducted

Finland, 

References & Publications (11)

Barnett AG, Dobson AJ, McElduff P, Salomaa V, Kuulasmaa K, Sans S; WHO MONICA Project. Cold periods and coronary events: an analysis of populations worldwide. J Epidemiol Community Health. 2005 Jul;59(7):551-7. — View Citation

Barnett AG, Sans S, Salomaa V, Kuulasmaa K, Dobson AJ; WHO MONICA Project. The effect of temperature on systolic blood pressure. Blood Press Monit. 2007 Jun;12(3):195-203. — View Citation

Bhaskaran K, Hajat S, Haines A, Herrett E, Wilkinson P, Smeeth L. Short term effects of temperature on risk of myocardial infarction in England and Wales: time series regression analysis of the Myocardial Ischaemia National Audit Project (MINAP) registry. BMJ. 2010 Aug 10;341:c3823. doi: 10.1136/bmj.c3823. — View Citation

Edwards DG, Gauthier AL, Hayman MA, Lang JT, Kenefick RW. Acute effects of cold exposure on central aortic wave reflection. J Appl Physiol (1985). 2006 Apr;100(4):1210-4. Epub 2005 Oct 13. — View Citation

Hintsala H, Kandelberg A, Herzig KH, Rintamäki H, Mäntysaari M, Rantala A, Antikainen R, Keinänen-Kiukaanniemi S, Jaakkola JJ, Ikäheimo TM. Central aortic blood pressure of hypertensive men during short-term cold exposure. Am J Hypertens. 2014 May;27(5):6 — View Citation

Ikäheimo TM, Lehtinen T, Antikainen R, Jokelainen J, Näyhä S, Hassi J, Keinänen-Kiukaanniemi S, Laatikainen T, Jousilahti P, Jaakkola JJ. Cold-related cardiorespiratory symptoms among subjects with and without hypertension: the National FINRISK Study 2002. Eur J Public Health. 2014 Apr;24(2):237-43. doi: 10.1093/eurpub/ckt078. Epub 2013 Jun 22. — View Citation

Komulainen S, Rintamäki H, Virokannas H, Keinänen-Kiukaanniemi S. Blood pressure responses to whole-body cold exposure: effect of metoprolol. J Hum Hypertens. 2004 Dec;18(12):905-6. — View Citation

Modesti PA, Morabito M, Massetti L, Rapi S, Orlandini S, Mancia G, Gensini GF, Parati G. Seasonal blood pressure changes: an independent relationship with temperature and daylight hours. Hypertension. 2013 Apr;61(4):908-14. doi: 10.1161/HYPERTENSIONAHA.111.00315. Epub 2013 Feb 4. — View Citation

Näyhä S. Environmental temperature and mortality. Int J Circumpolar Health. 2005 Dec;64(5):451-8. — View Citation

Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering TG, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G; ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010 Dec;24(12):779-85. doi: 10.1038/jhh.2010.54. Epub 2010 Jun 3. Review. — View Citation

Sun Z. Cardiovascular responses to cold exposure. Front Biosci (Elite Ed). 2010 Jan 1;2:495-503. Review. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Blood pressure response of hypertensive and normotensive subjects to cold exposure The study assesses the blood pressure response of hypertensive and normotensive subjects to facial cooling. Blood pressure is measured before (warm, +18°C), during (cold, 15°C) and after (warm, +18°C) the employed cold exposure. The duration of each of these exposures are 30, 15 and 30 min. 2 hours (measured within the controlled experiment) No
Secondary Cardiac autonomic regulation ECG is recorded continuously during the controlled experiment (15 min warm 18 C, 15 min cold exposure -15 C and 20 min 18 C) from where cardiac electrical function, as well as autonomic nervous system regulation is assessed. 2 hours (measured within each controlled experiment), ECG recorded continuously No
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A

External Links